Sartorius Stedim Biotech SA / Key word(s): AGM/EGM Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. 26-March-2024 / 16:18 CET/CEST Aubagne, France, March 26, 2024
Resolutions of the Annual Shareholders’ Meeting At today’s combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A., shareholders have granted discharge to all directors by a large majority and approved the renewal of the appointments as Directors of Susan Dexter and Anne-Marie Graffin for a three-year term of office. From March 26, 2024, onwards, the Board of Directors of Sartorius Stedim Biotech S.A. is composed of: Joachim Kreuzburg, Chairman; René Fáber, CEO; Pascale Boissel; Susan Dexter; Romaine Fernandes; Anne-Marie Graffin; Lothar Kappich; and Henri Riey. Sartorius Stedim Biotech shareholders approve dividend proposal This press release contains forward-looking statements about the future development of the Sartorius Stedim Biotech Group. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such statements. Sartorius Stedim Biotech assumes no liability for updating such statements in light of new information or future events. Sartorius Stedim Biotech shall not assume any liability for the correctness of this release. The French press release is the legally binding version. Press Images Financial calendar A profile of Sartorius Stedim Biotech Contact Follow Sartorius Stedim Biotech on LinkedIn. Attachment File: Press Release Dissemination of a Financial Wire News, transmitted by EQS Group. |
UVA researchers develop online tool to combat childhood diarrheal diseases
University of Virginia researchers are developing a flexible online tool for navigating information used in the fight to save children from deadly diarrheal diseases by